Shah, U A, Rögnvaldsson, S, Derkach, A, Björkholm, M, Turesson, I, David, Y, Hultcrantz, M, Tan, C, Hassoun, H, Korde, N, Lesokhin, A, Mailankody, S, Kristinsson, S Y & Ola Landgren, C 2022, 'Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls', Haematologica, vol. 107, no. 1, pp. 284-286. https://doi.org/10.3324/haematol.2021.278772

Funding Information: This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748 (UAS) and supported by grants from Swedish Cancer Society (MB), Parker Institute of Cancer Immunotherapy Career Development Award (YD, UAS), International Myeloma Society Career Development Award, Paula and Rodger Riney Foundation, American Society of Hematology Clinical Research Training Institute Award and TREC Training Workshop R25CA203650 (PI: Melinda Irwin) (UAS). Funding Information: Contributions: all authors participated in the writing and review of the manuscript. Additionally UAS and SR designed the study and performed data analysis; AD performed data analysis and designed statistical methods; MB and IT curated the data and were involved in study design conception; YD, SP, MH, CT, HH, NK, AL, and SM were involved in study design conception; SYK and COL curated the data, designed the study, and supervised the research project. Acknowledgments: the authors would like to thank Hannah Rice, BA, ELS for editorial assistance. Funding: this research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748 (UAS) and supported by grants from Swedish Cancer Society (MB), Parker Institute of Cancer Immunotherapy Career Development Award (YD, UAS), International Myeloma Society Career Development Award, Paula and Rodger Riney Foundation, American Society of Hematology Clinical Research Training Institute Award and TREC Training Workshop R25CA203650 (PI: Melinda Irwin) (UAS). Data sharing statement: The data included in study is built on multiple population-based registries including the medical records of Swedish citizens. Although the data has been made unidentifiable before analysis, ethical board approval does not permit data sharing.